CoChat
Sign Up
Cited by 665Bariatric Surgery and OutcomesPharmacology and Obesity TreatmentObesity, Physical Activity, Diet

The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.

Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice

Douketis, J D, Macie, C, Thabane, L, Williamson, D F·2005·International Journal of Obesity
DOI 10.1038/sj.ijo.0802982
Open this paper in CoChat — free account

Abstract

Background Obesity is a common health problem that requires a long-term care approach. We systematically reviewed long-term (> or =2 y) studies investigating dietary/lifestyle, pharmacologic, and surgical weight loss methods to assess (1) weight loss efficacy, defined by absolute weight loss and the proportion of subjects with > or =5% weight loss, (2) effects of weight loss on cardiovascular risk factors, and (3) applicability of findings from studies to everyday clinical practice.Methods The MEDLINE, HealthSTAR, and the Cochrane Controlled Trials databases were searched for studies investigating the long-term efficacy of weight loss methods in overweight and obese adults. Data were extracted for (i) weight loss after 1 y (pharmacologic studies only), 2 y, 3 y, and 4 y, (ii) proportion of subjects with > or =5% weight loss at the end of follow-up, and (iii) changes (end-of follow-up minus baseline values) in blood lipids, fasting blood glucose, and systolic and diastolic blood pressure.Results Dietary/lifestyle therapy provides <5 kg weight loss after 2-4 y, pharmacologic therapy provides 5-10 kg weight loss after 1-2 y, and surgical therapy provides 25-75 kg weight loss after 2-4 y. Weight loss of > or =5% baseline weight is not consistently associated with improvements in cardiovascular risk factors and these benefits appear to be intervention specific and occur mainly in people with concomitant cardiovascular risk factors. Weight loss studies have methodologic limitations that restrict the applicability of findings to unselected obese people assessed in everyday clinical practice. These limitations include an inadequate study duration, large proportions of subjects lost to follow-up, a lack of an appropriate usual care group, and a lack of reporting of outcomes in high-risk subgroups.Conclusions Dietary/lifestyle and pharmacologic weight loss interventions provide modest weight loss, and may improve markers of cardiovascular risk factors although these benefits occur mainly in patients with cardiovascular risks. Studies investigating weight loss have methodologic limitations that restrict the applicability of findings to obese patients assessed in clinical practice.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.ijo.0802982

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 121 references

Research works printed but not linked: 2

  1. Collins R, MacMahon S . Blood pressure, antihypertensive drug treatment on vascular disease: reappraisal of the evidence in 1994. J Vasc Med Biol 1994; 50: 272–298.
  2. ACP Journal Club: purpose and procedures. Available at http://www.acpjc.org/shared/purpose and procedure.htm Accessed December 2003.

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Douketis, J. D., Macie, C., Thabane, L., & Williamson, D. F.
Affiliations
  • McMaster University (CA)
  • Centers for Disease Control and Prevention (US)
Corresponding author
Douketis, J D
ORCID
Venue
International Journal of Obesity
Publisher
Springer Science and Business Media LLC
Published
2005-07-05
Volume
29
Issue
10
Pages
1153-1167
ISSN
  • 0307-0565 (ISSN-L)
  • 1476-5497
DOI
10.1038/sj.ijo.0802982
OpenAlex
W2050986291
Cited by
665
References
121
Citations by year
2026: 16 · 2025: 20 · 2024: 20 · 2023: 20 · 2022: 21 · 2021: 34 · 2020: 30 · 2019: 27 · 2018: 36 · 2017: 35 · 2016: 42 · 2015: 41 · 2014: 55 · 2013: 44 · 2012: 39
FWCI
4.60
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • International Journal of Obesity (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
obesity, long-term weight loss, weight loss efficacy, bariatric surgery, cardiovascular risk factors, serum lipids, blood glucose, blood pressure, overweight adults
MeSH terms
Adolescent, Adult, Aged, Cardiovascular Diseases, Diet, Reducing, Female, Humans, Life Style, Male, Middle Aged, Obesity, Weight Loss, Randomized Controlled Trials as Topic, Anti-Obesity Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review